Visualizing the mind and body to spark behavioral change. Evcare is dedicated to advancing human well-being through cutting-edge hormone measurement technology derived from academic research. We specialize in analyzing biomarkers found in hair, nails, and saliva. Our core services include: R&D Support: Accelerating product development with scientific evidence. Corporate Wellness: Providing objective stress checks based on physiological data, moving beyond subjective surveys to true health visualization.
株式会社イヴケア（所在地：滋賀県大津市、代表取締役：五十棲計）は、犬の体毛中に含まれるホルモン指標を解析し、生活習慣病リスクをチェックする新サービス「WanScan（ワンスキャン）」を、2025年12月1日（月...
[画像1: https://prtimes.jp/i/127105/4/resize/d127105-4-cb3d55265bd9b7859a0e-0.png ] WanScanの検査キットはオーガニック素材を用いたオシャレな巾着袋型[画像2: https://prtimes.jp/i/127105/4/resize/d127...
[画像: https://prtimes.jp/i/127105/3/resize/d127105-3-e44590d5f0090cee5f65-1.png ] 株式会社イヴケア（本社：滋賀県大津市 代表：五十棲 計 以下、イヴケア）は、毛髪を活用したストレスおよび抗ストレス...
[画像1: https://prtimes.jp/i/127105/2/resize/d127105-2-a0f567995395531eb34c-1.png ] 滋賀県には、子どものプレイセラピーやアートセラピーを行うことのできる施設・機関が不足しています。 子どもは、言葉...
[画像1: https://prtimes.jp/i/127105/1/resize/d127105-1-a9b721967c541f16a114-0.png ] 当プログラムは、株式会社イヴケアが監修する、企業トップと人事・労務責任者が対象の先行エグゼクティブ研修です。 近...
Some children suffer from learning disabilities and experience difficulties in daily life due to poor eye movement, which makes it difficult to read and to play sports. We are developing an evidence-based system that uses eye tracking and eye movement indexing technologies to assess eye movements and provide training for children who are encountering these eyesight challenges. We are currently deploying this system in municipal consultation centers, elementary schools, and after-school day care centers.
A startup developing allogeneic T-cell therapies from pluripotent stem cells to provide novel treatments for advanced and recurrent cancers and immune-related diseases. Aiming to deliver the potential for a cure to diseases that were previously difficult to treat.
Utilizing the unique genome editing technology CRISPR-Cas3, C4U develops industrial applications to combat diseases that currently have no effective treatments.
A biotech startup developing T-cell and NK-cell therapies derived from low-immunogenicity iPS cells. It aims to provide new treatments for solid tumors and autoimmune diseases, contributing to the treatment of previously difficult-to-treat intractable diseases.
